Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
1.
Clin Microbiol Infect ; 25(7): 909.e1-909.e5, 2019 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-30991116

RESUMEN

OBJECTIVES: To provide species distribution and antifungal susceptibility profiles of 358 Trichosporon clinical isolates collected from 24 tertiary-care hospitals. METHODS: Species identification was performed by sequencing the IGS1 region of rDNA. Antifungal susceptibility testing for amphotericin B, fluconazole, voriconazole and posaconazole followed the Clinical and Laboratory Standards Institute reference method. Tentative epidemiologic cutoff values (97.5% ECVs) of antifungals for Trichosporon asahii were also calculated. RESULTS: Isolates were cultured mostly from urine (155/358, 43.3%) and blood (82/358, 23%) samples. Trichosporon asahii was the most common species (273/358, 76.3%), followed by T. inkin (35/358, 9.7%). Isolation of non-T. asahii species increased substantially over the last 11 years [11/77 (14.2%) from 1997 to 2007 vs. 74/281, (26.3%) from 2008 to 2018, p0.03]. Antifungal susceptibility testing showed high amphotericin B minimum inhibitory concentrations against Trichosporon isolates, with higher values for T. faecale. The ECV for amphotericin B and T. asahii was set at 4 µg/mL. Among the triazole derivatives, fluconazole was the least active drug. The ECVs for fluconazole and posaconazole against T. asahii were set at 8 and 0.5 µg/mL, respectively. Voriconazole showed the strongest in vitro activity against the Trichosporon isolates; its ECV for T. asahii was set at 0.25 µg/mL after 48 hours' incubation. CONCLUSIONS: Trichosporon species diversity has increased over the years in human samples, and antifungal susceptibility profiles were species specific. Trichosporon asahii antifungal ECVs were proposed, which may be helpful to guide antifungal therapy.


Asunto(s)
Antifúngicos/farmacología , Farmacorresistencia Fúngica , Trichosporon/clasificación , Trichosporon/efectos de los fármacos , Anfotericina B/farmacología , Brasil , ADN de Hongos/genética , ADN Ribosómico/genética , Fluconazol/farmacología , Humanos , Pruebas de Sensibilidad Microbiana , Técnicas de Tipificación Micológica , Centros de Atención Terciaria , Tricosporonosis/microbiología , Voriconazol/farmacología
2.
Neotrop Entomol ; 48(2): 323-331, 2019 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-30456722

RESUMEN

The number of Tetrastischus howardi (Olliff) females to be released and their dispersion should be known, that way, used D. saccharalis pupae as sentinel host to measure parasitism as function of the release density of the parasitoid and its location in the field. Two sets of trials were run aiming first to define the number of parasitoids to be released and the dispersal of the parasitoid using plots in sugarcane commercial fields, respectively. Pieces of sugarcane stalk holding sentinel pupae were taken to the field and exposed to parasitism in both trials. The parasitoid was released at the rate of 20, 40, 80, and 160 females per sentinel pupa, except for the control plot without releasing. The parasitism rate was calculated based on the recovered pupae after 96 h of exposure time from releasing the parasitoids. The models estimated the best parasitism rate by releasing 102 parasitoids per pupa. In the second trial, sentinel pupae were arranged in five subsequent circles corresponding 4, 8, 12, 16, and 20 m around the central parasitoid releasing point at rate of 4, 8, 12, 16, and 18 pupae per circle. The mean estimated dispersal distance was 7.64 m, with a covering area of 80.07 m2. Based on these findings, release of T. howardi is recommended in 125 points per hectare of sugarcane at rate of 102 females per pupa of the pest aiming to achieve homogeneous distribution and parasitism.


Asunto(s)
Lepidópteros/parasitología , Control Biológico de Vectores/métodos , Saccharum , Avispas/fisiología , Distribución Animal , Animales , Femenino , Densidad de Población , Pupa/parasitología
3.
Arq. Inst. Biol ; 76(3)2009.
Artículo en Portugués | LILACS-Express | VETINDEX | ID: biblio-1462044

RESUMEN

ABSTRACT The objective of this study was to determine the occurrence of aflatoxins in the corn used as poultry feed in the state of Bahia, Brazil. Eighty samples of corn were collected from two poultry feed factories between February 2005 and January 2006. The aflatoxins analyses were performed using a fluorometric technique with commercial immunoaffinity columns (Aflatest®, Vicam). The results revealed contamination in 8 (10%) of the samples, with levels varying from 1 to 5 ?g/kg. These results reflect the good quality of this product in regard to contamination by aflatoxins.


RESUMO O objetivo deste estudo foi determinar a ocorrência de aflatoxinas (AFs) em milho destinado à alimentação de aves no Estado da Bahia. Oitenta amostras de milho foram coletadas de duas fábricas produtoras de ração durante o período de fevereiro de 2005 a janeiro de 2006. As análises de AFs foram realizadas por meio da técnica de fluorimetria com colunas de imunoafinidade (Aflatest®, Vicam). Os resultados revelaram que oito (10%) amostras estavam contaminadas, com níveis variáveis de 1 a 5 ?g/kg. Estes resultados demonstram a boa qualidade do produto quanto à contaminação por aflatoxinas.

5.
Arq. bras. med. vet. zootec ; 58(2): 276-278, abr. 2006. ilus
Artículo en Inglés | VETINDEX | ID: vti-6833

RESUMEN

Empregaram-se os métodos cromatográficos de afinidade metálica e de imunoafinidade para purificação da toxina beta em sobrenadante de cultivo de Clostridium perfringens tipo C. Observaram-se, na eletroforese das primeiras frações eluidas nos dois métodos de purificação, uma banda de peso molecular aproximado de 38kDa, característica da forma monomérica de toxina beta de Clostridium perfringens tipo C, e bandas de peso moleculares superiores, referentes às suas formas oligoméricas. Maior rendimento foi obtido com a utilização do método de imunoafinidade.(AU)


Asunto(s)
Clostridium perfringens/aislamiento & purificación , Ensayo de Inmunoadsorción Enzimática
6.
Arq. bras. med. vet. zootec ; Arq. bras. med. vet. zootec. (Online);58(2): 276-278, abr. 2006. ilus
Artículo en Inglés | LILACS | ID: lil-432681

RESUMEN

Empregaram-se os métodos cromatográficos de afinidade metálica e de imunoafinidade para purificação da toxina beta em sobrenadante de cultivo de Clostridium perfringens tipo C. Observaram-se, na eletroforese das primeiras frações eluidas nos dois métodos de purificação, uma banda de peso molecular aproximado de 38kDa, característica da forma monomérica de toxina beta de Clostridium perfringens tipo C, e bandas de peso moleculares superiores, referentes às suas formas oligoméricas. Maior rendimento foi obtido com a utilização do método de imunoafinidade.


Asunto(s)
Clostridium perfringens/aislamiento & purificación , Ensayo de Inmunoadsorción Enzimática
7.
Bone Marrow Transplant ; 34(2): 111-4, 2004 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-15094755

RESUMEN

Influenza infection can be severe in bone marrow transplant (BMT) recipients. Although yearly epidemics occur worldwide, and a higher risk of complication is expected in these patients, few studies have addressed the impact of the new neuraminidase inhibitors in the prognosis of influenza after BMT. Influenza A or B infections were found in 39 of the 66 patients (59%) showing a positive nasal wash by DFA. Influenza A was diagnosed in 18 patients and influenza B in 23 patients; two patients were infected by influenza A and B with 84- and 90-day intervals between episodes, respectively. Of the 41 episodes (61%) of influenza A or B, 25 infections occurred during the spring and summer months. Oseltamivir was introduced within 48 h of symptoms appearing. Only two patients (5.1%) developed influenza pneumonia, and no patient died of influenza. A total of 22 patients (56.4%) acquired influenza before day +180 when preventive vaccination strategies are precluded owing to poor immunogenicity of the vaccine during this period. Oseltamivir proved to be safe and appears to have played an important role in the outcome of influenza infection in this population. The therapeutic and/or prophylactic benefits of Oseltamivir in BMT recipients remain to be demonstrated in randomized, prospective trials.


Asunto(s)
Acetamidas/uso terapéutico , Trasplante de Médula Ósea/efectos adversos , Gripe Humana/prevención & control , Antivirales/uso terapéutico , Estudios de Seguimiento , Neoplasias Hematológicas/complicaciones , Neoplasias Hematológicas/terapia , Humanos , Gripe Humana/tratamiento farmacológico , Gripe Humana/etiología , Alphainfluenzavirus , Betainfluenzavirus , Líquido del Lavado Nasal , Oseltamivir , Premedicación , Estaciones del Año , Resultado del Tratamiento
8.
Water Sci Technol ; 48(6): 295-9, 2003.
Artículo en Inglés | MEDLINE | ID: mdl-14640231

RESUMEN

The purpose of this present paper is to verify the performance of three wetland systems operated with effluents from a UASB reactor, with respect nutrient removal (nitrogen and phosphorus), pathogenic organisms and remaining carbonaceous material, monitored over a three-year period. The experiment was carried out and monitored at PROSAB (Programa de Saneamento Básico) in Campina Grande, Paraíba. The removal efficiency of the carbonaceous material expressed in DQO ranged from 70 to 86%, but concerning the total suspended solids, the efficiency ranged from 50 to 71%. The removal efficiency in terms of nitrogen and phosphorus of both vegetated systems was about 65.5 to 86%, respectively, during the first year of operation. Under the operational conditions of the experiment, the removal of phosphorus in a wetland system containing washed sand as the substratum decreased, as its operation period increased. The vegetated wetland has been the most efficient in removing faecal coliforms (roughly 4 log units) as compared to the non-vegetated one (about 3 log units), when both were operated with the same hydraulic load (2.3 cm. per day). Thus, the effluent produced over the three-year period ranged from 800 to 1,800 UFC/100 mL in the analyzed samples.


Asunto(s)
Bacterias Anaerobias/fisiología , Reactores Biológicos , Ecosistema , Eliminación de Residuos Líquidos/métodos , Enterobacteriaceae , Nitrógeno/aislamiento & purificación , Fósforo/aislamiento & purificación
9.
Bone Marrow Transplant ; 31(8): 695-700, 2003 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-12692610

RESUMEN

Respiratory viruses (RVs) frequently cause severe respiratory disease in bone marrrow transplant (BMT) recipients. To evaluate the frequency of RV, nasal washes were collected year-round from BMT recipients with symptoms of upper respiratory tract infection (URI). Direct immunofluorescence assay was performed for respiratory syncytial virus (RSV), influenza (Flu) A and B, adenovirus and parainfluenza (Paraflu) virus. Patients with RSV pneumonia or with upper RSV infection, but considered at high risk for developing RSV pneumonia received aerosolized ribavirin. Oseltamivir was given to patients with influenza. A total of 179 patients had 392 episodes of URI. In all, 68 (38%) tested positive: RSV was detected in 18 patients (26.4%), Flu B in 17 (25%), Flu A in 11 (16.2%) and Paraflu in 7 (10.3%). A total of 14 patients (20.6%) had multiple RV infections or coinfection. RSV pneumonia developed in 55.5% of the patients with RSV-URI. One of the 15 patients (6.6%) with RSV pneumonia died. Influenza pneumonia was diagnosed in three patients (7.3%). RSV and influenza infections peaked in fall-winter and winter-spring months, respectively. We observed decreased rates of influenza and parainfluenza pneumonia and low mortality because of RSV pneumonia. The role of antiviral interventions such as aerosolized ribavirin and new neuraminidase inhibitors remains to be defined in randomized trials.


Asunto(s)
Trasplante de Médula Ósea/efectos adversos , Neoplasias Hematológicas/terapia , Complicaciones Posoperatorias/virología , Infecciones por Respirovirus/epidemiología , Acetamidas/uso terapéutico , Aerosoles , Antígenos Virales/sangre , Antivirales/uso terapéutico , Trasplante de Médula Ósea/clasificación , Técnica del Anticuerpo Fluorescente Indirecta , Neoplasias Hematológicas/clasificación , Humanos , Gripe Humana/epidemiología , Gripe Humana/mortalidad , Gripe Humana/prevención & control , Oseltamivir , Infecciones por Paramyxoviridae/epidemiología , Infecciones por Paramyxoviridae/mortalidad , Infecciones por Paramyxoviridae/prevención & control , Complicaciones Posoperatorias/mortalidad , Infecciones por Respirovirus/mortalidad , Infecciones por Respirovirus/prevención & control , Ribavirina/administración & dosificación , Ribavirina/uso terapéutico , Trasplante Autólogo , Trasplante Homólogo , Esparcimiento de Virus
10.
Acta Haematol ; 107(4): 187-94, 2002.
Artículo en Inglés | MEDLINE | ID: mdl-12053145

RESUMEN

Allogeneic bone marrow transplantation (ALLOBMT) is associated with an increased risk of cytomegalovirus (CMV) morbidity compared to autologous BMT (AUTOBMT). To investigate this, we evaluated AUTOBMT and ALLOBMT patients regarding anti-CMV immune reconstitution at 1 and 4 months after BMT and on the day after first CMV antigenemia detection. Intermittent ganciclovir preemptive therapy was prompted by antigenemia of >or=2 cells. One month after transplant, AUTOBMT recipients already displayed larger CD8+ T cell numbers than ALLOBMT recipients, but comparably small CD4+ T cell numbers. Most AUTOBMT patients had positive CMV antigen (CMV-Ag)-induced lymphoproliferation (86%) and IFN-gamma secretion (86%), whereas this was infrequently seen in ALLOBMT patients (20 and 10%, respectively). This early AUTOBMT immune reconstitution was associated with a lower frequency of CMV reactivation up to +4 months in AUTOBMT (21%) than ALLOBMT patients (91%). At +4 months, most ALLOBMT recipients had also recovered CMV-Ag immune responses. At first antigenemia detection, all 3 AUTOBMT recipients already displayed anti-CMV immune functions and 2 cleared the infection without therapy, whereas of the 10 ALLOBMT recipients only 1 had positive lymphoproliferation. In the latter group, none had IFN-gamma secretion or cleared the infection without therapy. Thus, differences in anti-CMV immune reconstitution may help to explain the contrasting rates of CMV morbidity between ALLOBMT and AUTOBMT patients.


Asunto(s)
Trasplante de Médula Ósea/inmunología , Infecciones por Citomegalovirus/inmunología , Citomegalovirus/inmunología , Interferón gamma/biosíntesis , Activación de Linfocitos , Trasplante Autólogo/inmunología , Trasplante Homólogo/inmunología , Viremia/inmunología , Adolescente , Adulto , Antígenos Virales/sangre , Linfocitos T CD4-Positivos/inmunología , Linfocitos T CD8-positivos/metabolismo , Citomegalovirus/crecimiento & desarrollo , Femenino , Enfermedad Injerto contra Huésped , Humanos , Inmunocompetencia , Recuento de Linfocitos , Masculino , Persona de Mediana Edad , Neoplasias/inmunología , Neoplasias/terapia , Acondicionamiento Pretrasplante , Activación Viral
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA